Looks like investors are wising up

[anonymous]

Looks like investors are seeing through the razzle dazzle that is being put out there. Doesn't look like they bought into the earnings story.

 

[anonymous]

Looks like investors are seeing through the razzle dazzle that is being put out there. Doesn't look like they bought into the earnings story.

Not one mention of Ofirmev!

 

[anonymous]

down $16 today at one point. Still yapping about transforming organization, operationnal efficiencies (more cuts???). No confidence whatsoever but for a gambler the -16 represents an opportunity to make a few quick bucks as it will rise up a little say -10.
Need another purchase quick to kerp the scherade going!!!!

 

[anonymous]

"Where did you get those clothes? The toilet store?"--Brick Tamland

 

[anonymous]

They didn not get rid of enough dead wood

 

[anonymous]

Thanks Mark. Please let us know if we can take a mutual separation package in advance

 

[anonymous]

please do not mention Ofirmev. (Only viable products please)

 

[anonymous]

Stock down 6.66 at 97.85. Get those revenue numbers up! Double that price again!!

 

[Warrin Buffit]

Mallinckrodt PLC's stock declined 5.76%, to close the day at $98.49. The stock recorded a trading volume of 6.47 million shares, much above its three months average volume of 1.12 million shares. Over the last one month and over the past three months, Mallinckrodt PLC's shares have plummeted 17.97% and 17.28%, respectively. Furthermore, the stock has lost 0.55% since the start of this year. The company's shares are trading 12.47% below their 200-day moving average. Additionally, Mallinckrodt PLC has an RSI of 20.70. The complimentary notes on MNK can be downloaded in PDF format at:

https://www.EquityResearchInstitute.com/reports?keyword=MNK



Read more: http://www.nasdaq.com/press-release...-catalyst-pharma-20150807-00357#ixzz3iAe2xv1K

 

[anonymous]

Time for a bounce.